Question 1

What is Enliven Therapeutics?

Accepted Answer

Enliven Therapeutics is a Entity.

Question 2

How often does Enliven Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Enliven Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Enliven Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Enliven Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Enliven Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Enliven Therapeutics?

Accepted Answer

Enliven Therapeutics Prices $400M Offering (Jun 11, 2026, 7 articles).

Question 8

How did the "Enliven Therapeutics Prices $400M Offering" event impact Enliven Therapeutics?

Accepted Answer

Enliven Therapeutics is the company conducting the public offering of its common stock and pre-funded warrants to raise approximately $400.0 million in gross proceeds, which will provide capital for its operations and development of small molecule therapeutics.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.